Our Pipeline and Products

Menarini is investing in advanced science and technology to develop a pipeline of new products that make a difference to the lives of patients affected by serious conditions.

MENARINI is a fully integrated privately owned pharma company with a long and successful heritage in strategic partnering across the globe. We have a profound know-how stemming from our strong R&D capabilities in key therapeutic areas, coupled with our excellence in commercial execution and our powerful direct presence on a global basis.

Share your partnering idea

Our dedicated Corporate Business Development team is committed to assess and explore innovative new opportunities.

 

Donations of backpacks and cases for school, distribution of meals and medicines, promotion of sport, support for pregnant women and much more: being responsible for Menarini means transforming good intentions into concrete efforts. By helping others, we want to contribute to improve the world around us, starting with us.

Our Values

Everyday we put our values into action. 4 values, which have given life to Menarini and shaped its history.

 

What does it really make Menarini unique? The diversity and authenticity of our key resource - the People.
Our cultural diversity helps us to drive innovation, adapt to business changes, face challenges, inspire ideas and develop our growth.

Available positions on Linkedin

Menarini employees make all the difference, every day.

 

News

Italian Excellence Honored in Washington Lucia and Alberto Giovanni Aleotti Receive the Italpress Award for Menarini Group’s International Growth

Washington, October 2025 – A recognition coming from the heart of the United States, celebrating the entrepreneurial vision of those who have passionately led an Italian company toward a global dimension. Lucia and Alberto Giovanni Aleotti, shareholders and members of Menarini’s Board, have been awarded the Italpress Award, presented by the Italpress news agency as part of the celebrations for the 50th anniversary of the NIAF (National Italian American Foundation) - an event that annually honors individuals and organizations that enhance and promote the excellence of Made in Italy worldwide.

valeria-speroni-cardi-head-of-communications-menarini-group-daniela-santanche-minister-of-tourism-of-italy-gaspare-borsellino-founder-and-director-of-italpress-lucia-and-alberto-giovanni-aleotti-lucia-e-a.jpg
In the pictures from the left: Valeria Speroni Cardi, Head of Communications Menarini Group, Daniela Santanchè, Minister of Tourism of Italy, Gaspare Borsellino, Founder and Director of Italpress. Lucia and Alberto Giovanni Aleotti


The award was presented to Lucia and Alberto Giovanni Aleotti “for having successfully guided Menarini toward a global dimension, transforming it into one of the most recognized companies in the international pharmaceutical landscape. Their decision to reinvest all profits into the Group’s growth has strengthened the company’s research and internationalization, with Menarini now present in 140 countries. With the acquisition of Stemline Therapeutics in New York, Menarini opened a new chapter in the history of oncology, becoming synonymous with innovation, quality, and social commitment — a journey that reflects the strength of Italian leadership in the world.”

“We would like to thank Italpress, and especially Gaspare Borsellino, for this award and for the passion with which he tells the story of an Italy that works, innovates, and grows every day,” said Lucia and Alberto Giovanni Aleotti, shareholders and members of Menarini’s Board. “Being recognized in a setting like Washington, which celebrates Italian excellence around the world, is for us a sign of esteem that gives value to our entrepreneurial vision. We wish to share this recognition with our CEO, Elcin Barker Ergun, whose pivotal role in expanding Menarini’s presence in the United States has marked a new chapter in the Group’s history.”